SCHEMBL30644443

SCHEMBL30644443

Cc1cc(Br)nc(/C=N/O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ NOS2 P35228 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HPGD P15428 3/20 0.33
▸ MAPT P10636 3/20 0.33
▸ CTH P32929 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26643704 1.00 GAA (0.38) GAAMAPK1NOS2NPC1RAB9A
SCHEMBL26644345 1.00 GAA (0.38) GAAMAPK1NOS2NPC1RAB9A
SCHEMBL13730536 0.81 GAA (0.38) GAAMAPK1NPC1RAB9AHSP90AA1
SCHEMBL13730537 0.81 GAA (0.38) GAAMAPK1NPC1RAB9AHSP90AA1
SCHEMBL6792348 0.80 GAA (0.44) GAAMAPK1NOS2NPC1RAB9A
SCHEMBL31322979 0.77 HSP90AA1 (0.54) GAAMAPK1NPC1RAB9AHSP90AA1
SCHEMBL26643452 0.77 HSP90AA1 (0.54) GAAMAPK1NPC1RAB9AHSP90AA1
SCHEMBL12990641 0.74 NOS2 (0.37) NOS2MAPTKDM4EALDH1A1
SCHEMBL1821173 0.71 — —
SCHEMBL20412761 0.69 CCR1 (0.53) GAAMAPK1NOS2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282768-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-09-11 — — US disclosed
EP-4522607-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF-kB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2025-03-19 — — EP disclosed
CN-119317626-A Pyrrolidone derivatives as inhibitors of NF- κb-induced kinase 詹森药业有限公司 2025-01-14 — — CN disclosed
WO-2023217851-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF-κB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282768-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB GAA 2050/4885MAPK1 356/4885NOS2 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback